
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
| Revenue (TTM) | $200.42B |
| Gross Profit (TTM) | $51.89B |
| EBITDA | $8.54B |
| Operating Margin | 5.30% |
| Return on Equity | 12.10% |
| Return on Assets | 3.98% |
| Revenue/Share (TTM) | $901.35 |
| Book Value | $201.97 |
| Price-to-Book | 2.02 |
| Price-to-Sales (TTM) | 0.45 |
| EV/Revenue | 0.553 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -16.80% |
| Quarterly Revenue Growth (YoY) | 2.60% |
| Shares Outstanding | $217.16M |
| Float | $216.71M |
| % Insiders | 0.18% |
| % Institutions | 93.38% |
Volatility is currently expanding

Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2026 financial results on July 15, 2026, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-39.

ELV seeks to recover an estimated $115 million through a CMS lawsuit over Medicare Advantage Star Ratings and disputed bonus payments.

Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.

INDIANAPOLIS--(BUSINESS WIRE)--The No Surprises Act was created to protect patients from unexpected medical bills. While those patient protections are working, new research from the Elevance Health Public Policy Institute suggests that the law's payment dispute process is producing unexpected results for some planned medical procedures. The findings come as federal IDR volume has grown far beyond initial projections, raising concerns that a process intended as a limited payment-dispute backstop.

INDIANAPOLIS--(BUSINESS WIRE)--Thomas Carr Howe Middle School today celebrated the unveiling of a newly transformed fitness and strength training space made possible through a partnership with Elevance Health and the Impact Fitness Foundation (IFF). The project marks the fifth consecutive year that Elevance Health and IFF have invested in Indianapolis schools through community fitness initiatives connected to the Elevance Health Women's Fort Myers Tipoff, a premier collegiate basketball tournam.

Elevance Health's Health OS is cutting review delays and admin work, with early results showing fewer denials and holds as digital healthcare adoption expands.

Elevance Health (ELV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ELV surpasses $1B in affordable housing investments, aiming to improve health outcomes, expand care access and support long-term growth.

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.